Skip to main content

Table 2 Treatment characteristics

From: Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma

Patient

Age

Site treated

Prescribed dose (Gy)

Fractions (n)

PTV volume (cc)

PTV maximum dose (Gy)

PTV minimum dose (Gy)

PTV mean dose (Gy)

1

56

Liver

50

5

30.5

59.8

35.8

55.3

 

57

Liver

45

5

16.0

49.4

36.5

46.4

 

57

Lymph node

45

5

30.4

49.1

34.9

45.7

2

59

Liver

50

5

412.4

56.8

35.0

53.4

3

69

Liver

60

3

67.0

68.9

52.9

65.4

4

82

Liver

60

5

150.2

76.2

48.7

68.2

5

56

Liver

45

5

91.2

52.4

31.9

47.8

6

51

Liver

60

5

224.3

65.1

25.0

60.6

7

70

Liver

60

3

26.6

64.7

55.5

61.9

8

64

Liver

60

5

121.5

68.5

26.5

61.5

9

67

Adrenal

50

5

61.0

54.5

45.4

51.6

10

87

Liver

60

5

133.5

75.7

12.1

62.2